Artificial Intelligence (AI) is one of the hottest topics in healthcare currently. The subject is permeating most industries, and breast imaging is no different. Many may wonder how the use of AI...
On April 30, 2024 the U.S. Preventive Services Task Force (USPSTF) published the final version of their recommendation on screening mammography guidelines and while not unexpected, the...
Mammographic screening in the general population has a proven record of decreasing death rates from breast cancer primarily by early detection, whether it's finding cancers smaller and sooner than...
On May 9, 2023 the US Preventive Services Task Force publicly presented their new recommendation statement on breast cancer screening and sought public comment from May 9 through June 5, 2023. Their...
Beekley Medical® recently had the pleasure of exhibiting at the National Consortium of Breast Centers (NCoBC) Interdisciplinary Breast Center Conference in Las Vegas, NV. While we were able to make...
Racial disparities exist across the whole spectrum of healthcare, and the detection of breast cancer is no exception. Breast cancer is the second most common cancer among women – in fact 1 in 8 women...
It is well established that the two biggest risk factors for breast cancer are gender (being female) and age (getting older). More than 75% of women diagnosed with breast cancer have no known family...
When the FDA approved the first digital breast tomosynthesis (DBT) unit (Hologic-Selenia Dimensions) in February 2011, it was mandated that a two-dimensional (2D) mammogram was acquired along with...
Digital breast tomosynthesis, or 3D Mammography, is the latest advancement in breast imaging that has everyone talking, including my mother and her friends.
